Federal Register of Legislation - Australian Government

Primary content

PB 75 of 2013 Determinations/Health as made
This determination amends the National Health (Price and Special Patient Contribution) Determination 2010 (No. PB 109 of 2010) by adding new brand premiums to three brands of pharmaceutical items, removing one brand premium and provides the increasing or decreasing brand premiums to other brands of pharmaceutical items.
Administered by: Health
Registered 28 Nov 2013
Tabling HistoryDate
Tabled HR02-Dec-2013
Tabled Senate02-Dec-2013
Date of repeal 02 Dec 2013
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

 

PB 75 of 2013

National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 7)

National Health Act 1953

I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 26 NOVEMBER 2013

 

 

 

 

 

 

 

 

 

FELICITY MCNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health


 


1          Name of Instrument

            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 7).

            (2)        This Instrument may also be cited as PB 75 of 2013.

2          Commencement

            This Instrument commences on 1 December 2013.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).



Schedule 1     Amendments

 

[1]      Schedule 1, entry for Allopurinol in the form Tablet 100 mg [Pricing Quantity/Pack Quantity 200]

omit from the column headed “Claimed Price”:          6.33        substitute:             7.51

[2]      Schedule 1, entry for Allopurinol in the form Tablet 300 mg

omit from the column headed “Claimed Price”:          4.41        substitute:             5.75

[3]      Schedule 1, entry for Amoxycillin in the form Capsule 250 mg (as trihydrate)

omit from the column headed “Claimed Price”:          1.42        substitute:             3.44

[4]      Schedule 1, entry for Amoxycillin in the form Capsule 500 mg (as trihydrate)

omit from the column headed “Claimed Price”:          2.27        substitute:             4.28

[5]      Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          1.34        substitute:             3.35

[6]      Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          1.66        substitute:             3.68

[7]      Schedule 1, entry for Cefaclor in the form Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          5.91        substitute:             6.91

[8]      Schedule 1, entry for Cefaclor in the form Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

omit from the column headed “Claimed Price”:          6.27        substitute:             7.27

[9]      Schedule 1, entry for Cefaclor in the form Tablet (sustained release) 375 mg (as monohydrate)

omit from the column headed “Claimed Price”:          7.92        substitute:             8.92

[10]    Schedule 1, entry for Cephalexin in the form Capsule 250 mg (anhydrous)

omit from the column headed “Claimed Price”:          3.78        substitute:             4.41

[11]    Schedule 1, entry for Cephalexin in the form Capsule 500 mg (anhydrous)

omit from the column headed “Claimed Price”:          5.77        substitute:             6.73


 

[12]    Schedule 1, entry for Cephalexin in the form Granules for oral suspension 125 mg per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          4.26        substitute:             4.95

[13]    Schedule 1, entry for Cephalexin in the form Granules for oral suspension 250 mg per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          5.73        substitute:             6.66

[14]    Schedule 1, entry for Colchicine

omit from the column headed “Claimed Price”:          4.39        substitute:             6.40

[15]    Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 5 mg

omit from the column headed “Claimed Price”:          5.97        substitute:             6.69

[16]    Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg

omit from the column headed “Claimed Price”:          7.85        substitute:             8.56

[17]    Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg

omit from the column headed “Claimed Price”:          9.18        substitute:             9.89

[18]    Schedule 1, entry for Felodipine in the form Tablet 2.5 mg (extended release)

omit from the column headed “Claimed Price”:          7.48        substitute:             7.31

[19]    Schedule 1, entry for Felodipine in the form Tablet 5 mg (extended release)

omit from the column headed “Claimed Price”:          9.32        substitute:             9.14

[20]    Schedule 1, entry for Felodipine in the form Tablet 10 mg (extended release)

omit from the column headed “Claimed Price”:          14.21     substitute:             14.03

[21]    Schedule 1, omit entry for Lansoprazole

[22]    Schedule 1, entry for Lisinopril in the form Tablet 5 mg

omit from the column headed “Claimed Price”:          5.88        substitute:             6.52

[23]    Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Prinivil 10]

omit from the column headed “Claimed Price”:          7.63        substitute:             8.27

[24]    Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Zestril]

omit from the column headed “Claimed Price”:          7.62        substitute:             8.26


 

[25]    Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Prinivil 20]

omit from the column headed “Claimed Price”:          8.98        substitute:             9.63

[26]    Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Zestril]

omit from the column headed “Claimed Price”:          8.98        substitute:             9.63

[27]    Schedule 1, entry for Mometasone in the form Cream containing mometasone furoate 1 mg per g, 15 g

omit from the column headed “Claimed Price”:          7.43        substitute:             7.88

[28]    Schedule 1, entry for Mometasone in the form Lotion containing mometasone furoate 1 mg per g, 30 mL

omit from the column headed “Claimed Price”:          10.37     substitute:             10.81

[29]    Schedule 1, entry for Mometasone in the form Ointment containing mometasone furoate 1 mg per g, 15 g

omit from the column headed “Claimed Price”:          7.43        substitute:             7.88

[30]    Schedule 1, entry for Nitrazepam

(a)   omit from the column headed “Determined Price”:             1.13        substitute:             1.50

(b)   omit from the column headed “Claimed Price”:                  2.31        substitute:             2.68

[31]    Schedule 1, entry for Nystatin

omit from the column headed “Claimed Price”:          5.44        substitute:             6.25

[32]    Schedule 1, entry for Omeprazole

omit from the column headed “Claimed Price”:          11.00     substitute:             11.66

[33]    Schedule 1, entry for Paroxetine

omit from the column headed “Claimed Price”:          6.78        substitute:             8.09

[34]    Schedule 1, entry for Prednisolone in the form Oral solution 5 mg (as sodium phosphate) per mL, 30 mL

omit from the column headed “Claimed Price”:          8.60        substitute:             8.88

[35]    Schedule 1, entry for Simvastatin in the form Tablet 5 mg

omit from the column headed “Claimed Price”:          4.03        substitute:             5.23

[36]    Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Lipex 10]

omit from the column headed “Claimed Price”:          5.00        substitute:             6.20


 

[37]    Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Zocor]

omit from the column headed “Claimed Price”:          5.00        substitute:             6.20

[38]    Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Lipex 20]

omit from the column headed “Claimed Price”:          6.54        substitute:             7.74

[39]    Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Zocor]

omit from the column headed “Claimed Price”:          6.54        substitute:             7.74

[40]    Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Lipex 40]

omit from the column headed “Claimed Price”:          8.77        substitute:             9.96

[41]    Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Zocor]

omit from the column headed “Claimed Price”:          8.77        substitute:             9.96

[42]    Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Lipex 80]

omit from the column headed “Claimed Price”:          11.95     substitute:             13.15

[43]    Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Zocor]

omit from the column headed “Claimed Price”:          11.95     substitute:             13.15

[44]    Schedule 1, entry for Sucralfate

omit from the column headed “Claimed Price”:          17.02     substitute:             17.42

[45]    Schedule 1, after entry for Telmisartan in the form Tablet 80 mg

insert:

Telmisartan with Hydrochlorothiazide

Tablet 40 mg-12.5 mg

Oral

Micardis Plus 40/12.5 mg

28

6.68

8.71

 

Tablet 80 mg-12.5 mg

Oral

Micardis Plus 80/12.5 mg

28

16.69

18.71

 

Tablet 80 mg-25 mg

Oral

Micardis Plus 80/25 mg

28

18.10

20.13


 

[46]    Schedule 1, entry for Trimethoprim with Sulfamethoxazole in the form Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          3.48        substitute:             5.47

[47]    Schedule 1, entry for Trimethoprim with Sulfamethoxazole in the form Tablet 160 mg-800 mg

omit from the column headed “Claimed Price”:          3.46        substitute:             5.43